Skip to content
Screener

Treace Medical Concepts, Inc. TMCI Balance Sheet Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$12.61M+56.6%$9.54M-28.6%$10.71M-5.7%$7.69M-36.5%$8.05M-55.7%
$33.01M-46.1%$42.31M-32.5%$37.66M-41.5%$49.73M-29.6%$61.24M-20.3%
$28.73M-5.3%$30.36M-2.4%$42.16M+3.3%$32.96M+36.3%$30.33M+18.7%
$39.54M-6.7%$36.37M-4.1%$36.03M-8.2%$41.42M-5.0%$42.4M+2.7%
$120.45M-18.4%$123.47M-17.4%$132.05M-18.2%$138M-12.4%$147.6M-14.0%
$32.5M+9.4%$32.06M+18.2%$29.75M+14.6%$29.97M+19.1%$29.71M+22.5%
$12.82M0.0%$12.82M0.0%$12.82M0.0%$12.82M0.0%$12.82M0.0%
$6.65M-12.5%$6.89M-12.1%$7.13M-11.8%$7.36M-11.4%$7.6M-11.1%
$181.06M-12.3%$184.1M-10.6%$190.58M-12.2%$196.59M-7.7%$206.44M-8.7%
$16.06M-19.5%$13.54M+2.4%$6.73M-36.1%$16.1M-13.7%$19.96M+10.4%
$3.17M+185%$1.78M+3,847%$1.75M$1.8M$1.11M
$41.5M-1.0%$34.49M+4.0%$30.64M-12.3%$40.91M+6.9%$41.9M-5.7%
$56.04M+4.8%$55.82M+4.6%$55.58M+4.3%$53.53M+0.6%$53.45M+0.6%
$113.32M+4.1%$106.91M+6.4%$103.25M-0.9%$107.4M-0.6%$108.83M-4.5%
$65K+3.2%$65K+3.2%$64K+3.2%$64K+3.2%$63K+1.6%
-$282.83M-26.7%-$266.95M-29.6%-$248.99M-31.1%-$239.6M-26.4%-$223.31M-28.2%
$67.74M-30.6%$77.19M-26.7%$87.33M-22.6%$89.19M-15.0%$97.62M-13.0%
$181.06M-12.3%$184.1M-10.6%$190.58M-12.2%$196.59M-7.7%$206.44M-8.7%

FAQ

What are Treace Medical Concepts, Inc.'s total assets?
Treace Medical Concepts, Inc. (TMCI) holds $181.1M in total assets, down 12.3% year over year.
How much debt does Treace Medical Concepts, Inc. have?
Treace Medical Concepts, Inc. carries $72.7M in total debt against $67.7M of shareholders' equity, a debt-to-equity ratio of 1.07.
How much cash does Treace Medical Concepts, Inc. have?
Treace Medical Concepts, Inc. holds $12.6M in cash and equivalents.
Can Treace Medical Concepts, Inc. cover its short-term obligations?
Its current ratio is 2.90 — current assets exceed current liabilities.
Where does Treace Medical Concepts, Inc.'s balance sheet data come from?
Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.